Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-21-088971

Options or other derivatives

  • Director acquired 379,788 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Furey John Director 2021-07-01 Grant or award · Option to purchase Ordinary Shares +379,788 379,788 D
Loading xslF345X03/tm2121284-5_4seq1.xml…